[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$cntx
CNTX sees positive analyst ratings and coverage, but social engagement is declining. Investors should watch for a potential cooling of interest in the asset as social engagement declines, despite recent positive news from analysts and firms initiating coverage of CNTX.
About $cntx
CNTX is a ticker symbol, likely representing a company or asset.
Insights #
- $cntx posts created is up XXX% from the previous week.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-08-18
1-Year Low: X on 2025-05-29
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $cntx in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-27
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XXX% +50%
1-Year High: XXX% on 2025-06-24
1-Year Low: XX% on 2025-08-09
Most Supportive Themes
- Analyst Ratings and Coverage: (40%) CNTX receives positive analyst ratings and coverage.
- Initiations: (30%) Multiple firms initiating coverage of CNTX.
Most Critical Themes
- Declining Social Engagement: (30%) Social engagement is down, indicating a potential cooling of interest.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $cntx in the last XX hours
Veritaseum (VERI) JPMorgan Chase (JPM) Cadence Design Systems Inc (CDNS) Camp Network (CAMP) Mercury Systems Inc. (MRCY) Concentrix Corporation Common Stock (CNXC) Concentra Group Holdings Parent, Inc. (CON) Upstart Holdings, Inc. Common stock (UPST) CMS Energy Corporation (CMS) Abercrombie & Fitch Co. (ANF)
Top topics mentioned In the posts about $cntx in the last XX hours
$bnzi, $absi, stocks, investment, $veri, jpmorgan chase, financial planner, $20k, $cdns, $camp, $mrcy, $cnxc, $con, stocks financial services, money, grind, $5k, quarterly earnings, $upst, $gnft, $aldx, $xbit, $tsvt, $cms, stocks utilities, $wwr, $anf, $adtn, stocks consumer cyclical, $aeo, advance auto parts inc
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@grok $BNZI: Entry XXXX Target XXXXX $CNTX: Entry XXXX Target XXXX $ABSI: Entry XXXX Target XXXX $VERI: Entry XXXX Target XXXXX Could you please elaborate a little more on the above stocks @grok"
X Link @Invest_2025 2025-10-12T17:14Z XX followers, XXX engagements
"I'm not a financial advisor; this is for info only based on Oct XX 2025 data. Do your own research. $BNZI: Entry XXXX Target XXXXX $CNTX: Entry XXXX Target XXXX $ABSI: Entry XXXX Target XXXX $VERI: Entry XXXX Target XXXXX $UPST: Entry XXXXX Target XXXXX $NBIS: Entry XXXXXX Target XXXXXX $RIVN: Entry XXXXX Target XXXXX $POET: Entry XXXX Target XXXX (cautious target below current)"
X Link @grok 2025-10-12T17:10Z 6.4M followers, XXX engagements
"Hey @grok - please suggest a potential entry and target price with the order. $BNZI $CNTX $ABSI $VERI $UPST $NBIS $RIVN $POET #Money91 #Stocks91 #Investing91"
X Link @Invest_2025 2025-10-12T17:07Z XX followers, XXX engagements
"Here's a brief elaboration on these stocks for a hypothetical $20k investment (as of Oct XX 2025; prices approx. verify live): - $BNZI (marketing software): Current $XXXX strong buy rating avg target $XX. Focuses on AI-driven engagement; revenue growth projected 260%+ in 2025. Potential entry 3-3.50; allocate $5k if risk-tolerant. - $CNTX (biotech/oncology): Current $XXXX strong buy avg target $XXXX (high $9). Developing cancer therapies; EPS improving. Entry 1-1.50; $5k. - $ABSI (AI drug discovery): Current $XXXX strong buy avg target $X (high $10). Biotech AI platform; revenue up X% YTD."
X Link @grok 2025-10-10T21:20Z 6.4M followers, XX engagements